Recent News Headlines : Merck

Trending News Headlines : Merck

MERCK TO TAKE ON SUPERBUGS WITH CUBIST PHARMA BUY


Merck will pay 102 per share for Cubist, a premium of 37 percent to the Lexington, Massachussetts-based company's closing share price of 74... READ MORE

8th December, 2014 88

MERCK BUYS RIGHTS TO NEWLINK'S EXPERIMENTAL EBOLA VACCINE


NewLink, whose subsidiary licensed commercial rights to the rVSV-EBOV vaccine in 2010, said it would receive 50 million plus royalties from Merck... READ MORE

27th November, 2014 83

MERCK IN TALKS TO ACQUIRE CUBIST PHARMACEUTICALS FOR MORE THAN $7 BILLION


Merck in talks to acquire Cubist Pharmaceuticals for more than 7 billion NYT... READ MORE

6th December, 2014 81

MERCK TO TAKE ON SUPERBUGS WITH CUBIST PHARMA BUY


The Cubist deal is Merck's second big acquisition this year... READ MORE

9th December, 2014 56

BOBRIDGE SET FOR HOUR RECORD ATTEMPT


Melbourne will be the focus of the international cycling community on Saturday night when South Australian rider Jack Bobridge attempts to break the hour world record... READ MORE

28th January, 2015 40

WATCH WHERE YOU PUT THAT SELFIE STICK SAYS TDU


Still, nothing beats this guy, who took his telescopic monopoling to a whole new level at the 2014 Giro d'Italia, running alongside riders with his lengthy rod... READ MORE

25th January, 2015 26

BOBRIDGE READY TO GO TO HELL AND BACK IN PURSUIT OF HOUR RECORD


Fellow Australian Rohan Dennis will have a crack at the Hour Record in Switzerland on 8 February... READ MORE

30th January, 2015 0


IMPORTANT TERMS OF USE & DISCLAIMER INFORMATION:

Daily Digital News provides public access to an archive of historical news articles from many popular news sources. Daily Digital News provides keyword searchable summaries, and links, to news articles that were originally publically accessible, and all news articles presented on dailydigitalnews.com were initially freely available to the general public. Daily Digital News does not claim any copyright ownership of the aggregated content of this website. Aggregated news content presented on dailydigitalnews.com may be subject to copyright, and the use made here is consistent with the principles of limited use for research and education. Daily Digital News takes advantage of unique web-crawling technologies and algorithms. This includes the use of services provided by Alchemy API (by IBM Watson) as well as other open source technologies. Daily Digital News operates this website on a not for profit basis. No income, revenue, remuneration, or profit of any kind has been made as a result of providing this website to the public. Use of this website is at the user's own discretion. Daily Digital News exercises no control over the use made of this website and accepts no liability to users or resources in relation to the contents of, or use of, or otherwise in connection with this website. Full Terms & Conditions